IN BRIEF: EKF Diagnostics reports trading in line with expectations

Archived article

Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.

EKF Diagnostics Holdings PLC - Cardiff-headquartered medical diagnostics company - Trading update to December 31. Expects to report full-year revenue and adjusted earnings before interest, tax, depreciation and amortisation in-line with management expectations. This reflects continued steady growth from the Point-of-Care division and ?-HB sales. Reports good progress continues to be made in the Life Sciences division’s fermentation capacity expansion. Full-year results will be released late-March.

Current stock price: 29.50 pence

12-month change: down 32%

Copyright 2023 Alliance News Ltd. All Rights Reserved.